A demonstration of the in vitro bacterial mutagenicity of procarbazine, using the microtitre fluctuation test and large concentrations of S9 fraction

Carcinogenesis

Volumn 4, Issue 3, 1983, Pages 347-352

  Paes, D J ^a   Gatehouse, D G ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AROCLOR 1254; BETA NAPHTHOFLAVONE; MELPHALAN; PHENOBARBITAL; POLYCHLORINATED BIPHENYL; PROCARBAZINE;

AMES TEST; ANIMAL CELL; BIOLOGICAL MODEL; CHEMICAL MUTAGENESIS; DRUG ADMINISTRATION; DRUG EFFICACY; DRUG RESISTANCE; ESCHERICHIA COLI; HEREDITY; IN VITRO STUDY; LIVER; METHODOLOGY; MICROSOME; MUTAGENESIS; NONHUMAN; SALMONELLA;

ANIMAL; BIOTRANSFORMATION; ESCHERICHIA COLI; MALE; MICROSOMES, LIVER; MUTAGENICITY TESTS; MUTAGENS; MUTATION; PROCARBAZINE; RATS; RATS, INBRED STRAINS; SALMONELLA TYPHIMURIUM;

EID: 0020966360     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/4.3.347     Document Type: Article

References (31)

1. Spivack, S.D. (1974), Procarbazine, diagnosis and treatment, drugs five years later, Ann. Int. Med., 81, 795-800.
2. Lee, I.P. and Dixon, R.L. (1978), Mutagenicity, carcinogenicity and teratogenicity of procarbazine, Mu tat. Res., 55, 1-14.
3. Kefly, M.G., Gara, R.W., Yancey, S.T. and Botkin, C. (1968), Induction of tumours in rats with procarbazine hydrochloride, J. Natl. Cancer Inst., 40, 1027-1051.
4. Adler, I.D. (1980), A review of the co-ordinated research effort on the comparison of test systems for the detection of mutagenic effects, sponsored by the EEC Mutat. Res., 74, 77-93.
5. Bronzetti, G., Zeiger, E. and Mailing, H.V. (1979), Genetic toxicity of procarbazine in bacteria and yeast, Mutat. Res., 68, 51-58.
6. Gatehouse, D. (1981), Mutagenic activity of 42 coded compounds in the microtitre fluctuation test, in de Serres, R. and Ashby, J. (eds.), Evaluation of Short-Term Tests for Carcinogenesis, Elsevier/North Holland, pp.376-386.
7. Venitt, S., Pickering, S.P., HiIl, M.J. and Fernandez, F. (1981), The use of bacterial fluctuation tests in studies of mutagenic activity in extracts of human faeces, in Bruce, W.R., Correa, P., Lipkin, M., Tannenbaum, S.R. and Wilkins, T.D. (eds.), Banbury Repo rt, Gastrointestinal Cancer: Endogenous Factors, Cold Spring Harbor Laboratory, New York, pp. 239-245.
8. Levin, D.E., Blunt, E.L. and Levin, R.E. (1981), Modified fluctuation test for the direct detection of mutagens in foods with Salmonella typhimurium TA98; Mutat. Res., 85, 309-321.
9. Gatehouse, D.G. and Delow, G.F. (1979), The development of a microtitre fluctuation test for the detection of indirect mutagens, and its use in the evaluation of mixed-enzyme induction of the liver, Mutat. Res., 60, 239-252.
10. Ames, B.N., McCann, J. and Yamasaki, E. (1975), Methods for detecting carcinogens and mutagens with the Salmonella/rmcrosome mutagenicity test, Mutat. Res., 31, 347-364.
11. Bridges, B.A., Mottershead, R.P., Green, M.H.L. and Gray, W.S.H. (1973), Mutagenicity of dichlorvos and methylmethane sulphonate for E. coli WP2 and some derivatives deficient in DNA repair, Mutat. Res., 19,293-303.
12. Solt, A.K. and Neale, S. (1979), Induction of bacterial mutants in rodents treated with N-nitroso compounds, Mutât. Res., 64, 147.
13. Ichikawa, Y., Hagihara, B. and Yamano, T. (1967), Magnetic and spectrophotometric properties of the microsomal carbon monoxide binding pigment, Arch. Biochem. Biophys., 120, 204-213.
14. Eriksson-Grennberg, K.G., Boman, H.G., Torbjorn Jansson, J.A. and Thoren, S. (1965), Resistance of E. coti to penicillins. I. Genetic study of some ampicillin-resistant mutants, J. Bacteriol., 90, 54-62.
15. Forster, R., Green, M.H.L. and Priestley, A. (1980), Optimal levels of S9-fraction in the Ames and fluctuation tests: apparent importance of diffusion of metabolites from top agar, Carcinogenesis, 1, 337-346.
16. Gatehouse, D. (1980), Mutagenicity of 1,2-ring-fused acenaphthenes against S. typhimurium TA1537 and TA1538: structure-activity relationships, Mutât. Res., 78, 121-135.
17. Yahagi, T., Degawa, M., Seino, Y., Matsushima, T., Nagao M., Sugimura, T. 1975), Mutagenicities of carcinogenic azodyes and their derivatives, Cancer Lett., 1, 91-96.
18. Snedecor, G.W. and Cochran, W.G. (1967), Statistical Methods (6th Edition), published by Iowa State University Press, Ames, Iowa.
19. Moriya, M., Watanabe, K., Ohta, T. and Shirasu, Y. (1980), Detection of mutagenicity of procarbazine by the host-mediated assay with polychlorinated biphenyl (Aroclor 1254) as enzyme inducer, Mutât. Res., 79, 107-114.
20. Dunn, D.L., Lubet, R.A. and Prough, R.A. (1979), Oxidative metabolism of N-isopropyl-a-(2-methylhydrazino)-p-toluamide hydrochloride by rat liver, Cancer Res., 39, 4555-4563.
21. Weinkam, R.J. and Shiba, A., (1978), Metabolic activation of procarbazine, Life Sci., 22, 937-946.
22. Kreis, W. (1970), Metabolism of an anti-neoplastic methylhydrazine derivative in P815 mouse neoplasm, Cancer Res., 30, 82-89.
23. Mohn, G.R. and Ellenberger, J. (1979), Appreciation of the value of différait bacterial test systems for detecting and for ranking chemical mutagens, Arch. Toxicol., 46, 45-60.
24. Pueyo, C. (1979), Natulan induces forward mutuations to L-arabinose-resistance in Salmonella typhimurium, Mutât. Res., 67, 189-192.
25. Wilkinson, R.G., Gemski, P. and Stocker, B.A.D. (1972), Non-smooth mutants of Salmonella typhimurium. Differentiation by phage sensitivity and genetic mapping, J. Gen. Microb., 70, 527-554.
26. Solt, A.K. and Neale, S. (1980), Natulan, a bacterial mutagen requiring mammalian metabolic activation, Mutât. Res., 70, 167-171.
27. Tosk, J., Schmehz, I. and Hoffman, D. (1979), Hydrazines as mutagens in a histidine-requiring auxotroph of Salmonella typhimurium, Mutât. Res., 66, 247-252
28. McCann, J., Choi, E., Yamasaki, E. and Ames, B.N. (1975), Detection of carcinogens as mutagens in the Salmonella/miaosomt test: assay of 300 chemicals, Proc. Natl. Acad. Sci., 72, 5135-5139.
29. Rinkus, S. and Legator, M. (1979), Chemical characterisation of 465 known or suspected carcinogens and their correlation with mutagenic activity in the Salmonella typhimurium system, Cancer Res., 39, 3289-3318.
30. Toth, B. (1975), Synthetic and naturally occurring hydrazines as possible cancer causative agents, Cancer Res., 35, 3693-3697.
31. The Merck Index (1979), 9th Edition, published by Merck and Co. Inc., Rathway, NJ, USA.